Decision: Favourable

Study Title:

A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Professor Valerie Byrnes

  • PI Institution:

    University Hospital Galway

  • Sponsor:

    Dr Falk. Pharma GmbH

Scroll to Top
Skip to content